Cargando…

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database

Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhtar, Eldar, Wang, Mengyang, Zhu, Haimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293686/
https://www.ncbi.nlm.nih.gov/pubmed/34306166
http://dx.doi.org/10.2217/fvl-2021-0099
_version_ 1783725094944636928
author Muhtar, Eldar
Wang, Mengyang
Zhu, Haimei
author_facet Muhtar, Eldar
Wang, Mengyang
Zhu, Haimei
author_sort Muhtar, Eldar
collection PubMed
description Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson−Boltzmann surface area calculations were carried out. Results: The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson−Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. Conclusion: The study provides powerful in silico results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors.
format Online
Article
Text
id pubmed-8293686
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-82936862021-07-22 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Muhtar, Eldar Wang, Mengyang Zhu, Haimei Future Virol Short Communication Aim: SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. Materials & methods: An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson−Boltzmann surface area calculations were carried out. Results: The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson−Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. Conclusion: The study provides powerful in silico results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors. Future Medicine Ltd 2021-07-20 2021-07 /pmc/articles/PMC8293686/ /pubmed/34306166 http://dx.doi.org/10.2217/fvl-2021-0099 Text en © 2021 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Short Communication
Muhtar, Eldar
Wang, Mengyang
Zhu, Haimei
In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title_full In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title_fullStr In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title_full_unstemmed In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title_short In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
title_sort in silico discovery of sars-cov-2 main protease inhibitors from the carboline and quinoline database
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293686/
https://www.ncbi.nlm.nih.gov/pubmed/34306166
http://dx.doi.org/10.2217/fvl-2021-0099
work_keys_str_mv AT muhtareldar insilicodiscoveryofsarscov2mainproteaseinhibitorsfromthecarbolineandquinolinedatabase
AT wangmengyang insilicodiscoveryofsarscov2mainproteaseinhibitorsfromthecarbolineandquinolinedatabase
AT zhuhaimei insilicodiscoveryofsarscov2mainproteaseinhibitorsfromthecarbolineandquinolinedatabase